Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Biotech Companies
  • Healthcare Investors
  • Pharma News
  • Market Size & Market Analysis
  • Biotech Jobs

Tag Archives: innovative therapies Central Nervous System

Newron Pharmaceuticals – innovative therapies for Central Nervous System

Posted on by

Newron Pharmaceuticals is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the Central Nervous System (CNS) and pain.

Newron Pharmaceuticals – innovative therapies for Central Nervous System

Newron Pharmaceuticals

Continue reading →

Posted in Biotech Companies, Biotech Companies Clinical Stage, Biotech Companies CNS Neuroscience, Biotech Companies Drug Development, Biotech Companies Europe, Biotech Companies Italy, Biotech Companies Parkinson’s disease, Biotech Companies Preclinical Stage, Biotech Companies Rett Syndrome, Biotech Companies Schizophrenia, Biotech Companies Sweden, Biotech Companies Switzerland, Biotech Companies Therapeutics | Tagged add-on therapy, central nervous system, CNS, innovative therapies Central Nervous System, innovative therapies for Central Nervous System, Newron, Newron Pharmaceuticals, Newron Pharmaceuticals - innovative therapies for Central Nervous System, NW-3509, NWRN, pain, Parkinson, ralfinamide, rare disease, Rett syndrome, safinamide, sarizotan, Schizophrenia

Do you need to raise your next Funding round ? In-Licensing / Out-Licensing of your assets ? Want to create a spin-off with your IP ? Contact us!

Do you need access to our Healthcare database (investors, companies, CRO/CDMO, distributors, market analysis, etc.) ?   Contact us for more details and check our free DEMO.

Do you need to compare several quotes from CRO / CDMO ? We can help you for free ! Contact us .

Offers - Services - Licensing - Funding               Healthcare Venture Building               Biotech Jobs               Biotech & Pharma News              BioLeads
Proudly powered by WordPress